BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16502523)

  • 21. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of emesis associated with cancer chemotherapy.
    Robinson B
    N Z Med J; 1993 Feb; 106(950):52-4. PubMed ID: 8437759
    [No Abstract]   [Full Text] [Related]  

  • 24. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological means for eliminating vomiting as a complication of antitumor chemotherapy].
    Dolzhenko AT; Nalëtov SV
    Vopr Onkol; 1992; 38(5):527-33. PubMed ID: 1300750
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing nausea and vomiting after cancer treatments: patients still suffer unnecessarily.
    Molassiotis A
    Eur J Oncol Nurs; 2005 Mar; 9(1):4-5. PubMed ID: 15774335
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach.
    Gardani G; Cerrone R; Biella C; Galbiati G; Proserpio E; Casiraghi M; Arnoffi J; Meregalli M; Trabattoni P; Dapretto E; Giani L; Messina G; Lissoni P
    Minerva Med; 2007 Dec; 98(6):665-8. PubMed ID: 18299681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nausea and vomiting in cancer patients].
    Lévy E; Scotté F; Médioni J; Oudard S
    Rev Prat; 2006 Nov; 56(18):2015-9. PubMed ID: 17274504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing emesis in lung cancer patients.
    J Support Oncol; 2007 Feb; 5(2):79-80. PubMed ID: 17348365
    [No Abstract]   [Full Text] [Related]  

  • 32. Future of the management of emesis.
    Grunberg SM
    Support Care Cancer; 1994 Sep; 2(5):301-3. PubMed ID: 8000727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 34. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Nepal.
    Mallik S; Palaian S; Ojha P; Mishra P
    Pak J Pharm Sci; 2007 Jul; 20(3):214-8. PubMed ID: 17545106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
    Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
    Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiemetics].
    de Mulder PH
    Ned Tijdschr Geneeskd; 1987 Jun; 131(26):1107-11. PubMed ID: 2886927
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K; Lorenzen S; Rothling N; Ihbe-Heffinger A; Schuster T; Peschel C; Lordick F
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.